Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1

Cardiovasc Res. 2015 Jan 1;105(1):86-95. doi: 10.1093/cvr/cvu236. Epub 2014 Nov 10.

Abstract

Aims: The MEK5/Erk5 pathway mediates beneficial effects of laminar flow, a major physiological factor preventing vascular dysfunction. Forced Erk5 activation induces a protective phenotype in endothelial cell (EC) that is associated with a dramatically decreased migration capacity of those cells. Transcriptional profiling identified the Krüppel-like transcription factors KLF2 and KLF4 as central mediators of Erk5-dependent gene expression. However, their downstream role regarding migration is unclear and relevant secondary effectors remain elusive. Here, we further investigated the mechanism underlying Erk5-dependent migration arrest in ECs.

Methods and results: Our experiments reveal KLF2-dependent loss of the pro-migratory Rac/Cdc42 mediator, p21-activated kinase 1 (PAK1), as an important mechanism of Erk5-induced migration inhibition. We show that endothelial Erk5 activation by expression of a constitutively active MEK5 mutant, by statin treatment, or by application of laminar shear stress strongly decreased PAK1 mRNA and protein expression. Knockdown of KLF2 but not of KLF4 prevented Erk5-mediated PAK1 mRNA inhibition, revealing KLF2 as a novel PAK1 repressor in ECs. Importantly, both PAK1 re-expression and KLF2 knockdown restored the migration capacity of Erk5-activated ECs underscoring their functional relevance downstream of Erk5.

Conclusion: Our data provide first evidence for existence of a previously unknown Erk5/KLF2/PAK1 axis, which may limit undesired cell migration in unperturbed endothelium and lower its sensitivity for migratory cues that promote vascular diseases including atherosclerosis.

Keywords: Endothelial migration; Erk5; Krüppel-like factor; Laminar shear stress; PAK1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / etiology
  • Cell Movement / genetics
  • Cell Movement / physiology*
  • Down-Regulation
  • Endothelial Cells / metabolism
  • Endothelial Cells / physiology*
  • Gene Knockdown Techniques
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors / antagonists & inhibitors
  • Kruppel-Like Transcription Factors / genetics
  • Kruppel-Like Transcription Factors / metabolism*
  • MAP Kinase Kinase 5 / genetics
  • MAP Kinase Kinase 5 / metabolism
  • Mitogen-Activated Protein Kinase 7 / genetics
  • Mitogen-Activated Protein Kinase 7 / metabolism*
  • Models, Cardiovascular
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Signal Transduction
  • p21-Activated Kinases / genetics
  • p21-Activated Kinases / metabolism*

Substances

  • KLF2 protein, human
  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors
  • RNA, Messenger
  • PAK1 protein, human
  • p21-Activated Kinases
  • Mitogen-Activated Protein Kinase 7
  • MAP Kinase Kinase 5
  • MAP2K5 protein, human